Mettler-Toledo International (NYSE:MTD) Hits New 12-Month High – Still a Buy?
by Michael Walen · The Markets DailyShares of Mettler-Toledo International, Inc. (NYSE:MTD – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $1,552.82 and last traded at $1,538.8860, with a volume of 144004 shares trading hands. The stock had previously closed at $1,545.26.
Analyst Ratings Changes
A number of equities analysts have recently commented on the stock. Wells Fargo & Company increased their price objective on shares of Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the stock an “equal weight” rating in a research note on Monday, August 3rd. Royal Bank Of Canada started coverage on Mettler-Toledo International in a research report on Tuesday, September 1st. They issued a “sector perform” rating and a $1,515.00 target price on the stock. UBS Group started coverage on Mettler-Toledo International in a report on Wednesday, September 9th. They set a “neutral” rating and a $1,460.00 target price on the stock. Rothschild & Co Redburn began coverage on Mettler-Toledo International in a research report on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 price target for the company. Finally, Weiss Ratings raised Mettler-Toledo International from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, September 8th. Six research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and an average price target of $1,446.36.
Read Our Latest Analysis on Mettler-Toledo International
Mettler-Toledo International Trading Down 2.0%
The stock has a market cap of $29.66 billion, a price-to-earnings ratio of 33.31, a PEG ratio of 3.03 and a beta of 1.18. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45. The business’s 50 day simple moving average is $1,406.23 and its 200 day simple moving average is $1,288.48.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings data on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, topping the consensus estimate of $10.78 by $0.68. The company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. Mettler-Toledo International’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business earned $10.09 EPS. On average, research analysts expect that Mettler-Toledo International, Inc. will post 47.35 EPS for the current fiscal year.
Insiders Place Their Bets
In other Mettler-Toledo International news, CFO Shawn Vadala sold 2,240 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $1,432.00, for a total transaction of $3,207,680.00. Following the transaction, the chief financial officer owned 5,579 shares of the company’s stock, valued at $7,989,128. The trade was a 28.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Patrick Kaltenbach sold 942 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the completion of the sale, the chief executive officer owned 4,480 shares in the company, valued at $6,384,000. This represents a 17.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 4,254 shares of company stock worth $6,092,712. Company insiders own 0.71% of the company’s stock.
Institutional Investors Weigh In On Mettler-Toledo International
A number of large investors have recently added to or reduced their stakes in the business. Whipplewood Advisors LLC bought a new position in Mettler-Toledo International during the first quarter worth $25,000. Reflection Asset Management bought a new position in shares of Mettler-Toledo International in the fourth quarter valued at about $26,000. Edmond DE Rothschild Holding S.A. bought a new position in shares of Mettler-Toledo International in the second quarter valued at about $26,000. Transamerica Financial Advisors LLC acquired a new stake in shares of Mettler-Toledo International during the 2nd quarter worth about $32,000. Finally, Root Financial Partners LLC lifted its stake in shares of Mettler-Toledo International by 45.5% during the 1st quarter. Root Financial Partners LLC now owns 32 shares of the medical instruments supplier’s stock worth $40,000 after buying an additional 10 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.
About Mettler-Toledo International
Mettler-Toledo International Inc is a global manufacturer of precision instruments and related services used in laboratory, industrial, food processing, pharmaceutical and retail applications. The company’s solutions help customers measure, analyze, inspect and control materials and products throughout research, manufacturing and distribution processes.
Its product portfolio includes laboratory balances and scales, analytical instruments, automated chemistry systems, titrators, density and refractometry equipment, process analytics, industrial weighing systems, product inspection technologies and retail weighing and labeling solutions.
Further Reading
- Five stocks we like better than Mettler-Toledo International
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question